Trial Profile
Efficacy and safety of silodosin on lower urinary tract symptoms (LUTS) in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2015
Price :
$35
*
At a glance
- Drugs Silodosin (Primary)
- Indications Lower urinary tract symptoms
- Focus Therapeutic Use
- 10 Jul 2015 Status changed from not yet recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 04 Jul 2012 New trial record